Compugen Ltd at Jefferies Virtual London Healthcare Conference Transcript
Hi, everyone. Thanks so much for joining us. My name is Chris Howerton, I'm part of the Jefferies biotechnology equity research team. Very pleased to be hosting a fireside chat with next company, Compugen. We're obviously joined by the team here, but including: Anat, the CEO; Ari, the CFO; Henry, the clinical development lead; and Eran, the earlier-stage R&D development lead. So thanks for joining us, everybody.
Questions & Answers
Okay. Great. So maybe before we get started in terms of your lead programs in immuno-oncology, I'll note to the audience out here that you actually have a pretty extensive and robust drug discovery platform. So Anat or Eran, I don't know who would like to take this question, but would love to just kind of hear a little bit about the platform and how it is that you have arrived at your current portfolio of assets.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
